Harrisburg, PA – According to filings with the U.S. Securities and Exchange Commission, MacuLogix is raising $8,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, William Mcphee played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About MacuLogix

MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx dark adaptometer, MacuLogix enables eye care professional to detect, monitor and start treating AMD three years before it can be seen in order to prevent vision loss. MacuLogix provides in-practice training and best practices to support the effective and efficient implementation and use of the AdaptDx.

To learn more about MacuLogix, visit http://www.maculogix.com/

Contact:
William Mcphee, Chief Executive Officer
717-914-4067
wmcphee@maculogix.com
https://www.linkedin.com/in/bill-mcphee-974b897/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved